Abstract No. 552 Hepatotoxicity and Survival in Patients with Cirrhotic Hepatocellular Carcinoma versus Liver Metastatic Disease After Yttrium-90 Radioembolization

A total of 75% to 85% of hepatocellular carcinoma (HCC) cases are associated with underlying cirrhosis. Hepatotoxicity and radiation-induced liver disease (RILD) are known sequelae following Yttrium-90 (Y-90) trans-arterial radioembolization (TARE). The purpose of this study was to evaluate if patients with HCC from underlying cirrhosis have different hepatotoxicity or survival compared to patients with liver metastatic disease, who undergo Y-90 TARE.